Related Experiment Video

Updated: May 9, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Treatment patterns and survival outcomes in neuroendocrine neoplasms presenting with brain metastases

Zouina Sarfraz1, Tulika Ranjan2, Fatma Nihan Akkoc Mustafayev1

  • 1Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.

Journal of Neuro-Oncology
|May 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Brain metastasesNeuroendocrine neoplasmsOverall survivalStereotactic radiosurgerySystemic therapyTreatment patterns

More Related Videos

Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
07:42

Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection

Published on: January 16, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

Related Experiment Videos

Last Updated: May 9, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
07:42

Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection

Published on: January 16, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Articles linked to this work by shared authors, journal, and citation graph.

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Nature medicine·2026

Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung Cancer.

Cancer research·2026

Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.

Neuro-oncology advances·2026

Focused ultrasound for brain metastases.

Neuro-oncology advances·2026

Applications of transcranial focused ultrasound for primary brain tumors.

Neuro-oncology advances·2026

Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study.

Scientific reports·2026

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab.

Journal of neuro-oncology·2026

Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study.

Journal of neuro-oncology·2026

Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases.

Journal of neuro-oncology·2026

Prognostic value of the Evans index in neoplastic meningitis: a real-world cohort study.

Journal of neuro-oncology·2026

Integrating ex vivo platforms with AI to guide glioblastoma treatment.

Journal of neuro-oncology·2026

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.

Journal of neuro-oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us